Skip to main content
Erschienen in: European Journal of Nutrition 2/2021

Open Access 13.01.2021 | LETTER TO THE EDITOR

A systematic review and meta-analysis of 24-h urinary output of children and adolescents: impact on the assessment of iodine status using urinary biomarkers—don’t forget creatinine

verfasst von: Thomas Remer

Erschienen in: European Journal of Nutrition | Ausgabe 2/2021

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
This Letter to the Editor refers to the original publication available at: https://​doi.​org/​10.​1007/​s00394-019-02151-w.
A reply to this letter is available at: https://​doi.​org/​10.​1007/​s00394-020-02468-x.
To the Editor,
In a systematic review and meta-analysis on kidney´s 24-h urinary output of children and adolescents, recently published in the European Journal of Nutrition, Beckford et al. [1] reported that the average 24-h urine volume of children aged 2–12 years is lower than 1 L (L).
The WHO has set the biomarker criterion for iodine sufficiency at a cut-off of ≥ 100 µg iodine per 1 L, to be used for spot urine collections both in children and adults. Due to a marked age dependency of 24-h urine volumes from childhood to adulthood the referring to this fixed cut-off can result in a substantial misclassification of true iodine status of a population [2].
For example, in the former representative German-wide Health Interview and Examination Survey for Children and Adolescents (KiGGS-Wave 1), a median iodine concentration of 117 µg/L (according to WHO criteria reflecting iodine sufficiency) showed to be associated with a considerable proportion of around 30% of the German children and adolescents falling below their respective age-specific Estimated Average Requirement (EAR) values [3].
Accordingly, the 24-h urinary output data compiled in the systematic review by Beckford et al. [1] for the 3 age groups 2–5, 6–12, and 13–19 years olds, can represent a practical aid to estimate iodine status of children and youth on a per-day basis in a more differentiated way. However, it must be stated that also within these age groups and particularly during adolescence urinary volume variations, worth considering, exist. In an age- and sex-balanced cross-sectional study including 400 boys and girls in total, in which we had examined urinary glucocorticoid and androgen metabolite excretion rates, also 24-h urine volumes and further growth relevant parameters had been studied [4, 5]. These rather detailed data from the DONALD study, that may have been overlooked by Beckford et al. do not only underpin the presented results of Beckford et al.’s large review sample, but can also complement them with important additional growth-related characteristics, such as 24-h creatinine excretion rate, height, BMI, body surface area, and energy intake of healthy children and adolescents. Therefore, it has been found reasonable, to present these data here again (Table 1), putting them together from our two endocrinological papers on steroid excretions during human growth [4, 5].
Table 1
24-h urine volume and creatinine excretion rates as well as further characteristics of 400 healthy children and adolescents of the DONALD study in whom the steroid metabolome has been examined [4, 5]
Age years
Boys (n = 200)
Girls (n = 200)
Urine volume (mL/d)
Creatinine (mmol/d)
Height (cm)
BMI (kg/m2)
BSA (m2)
Daily energy intake, (cal/d)
Urine volume (mL/d)
Creatinine (mmol/d)
Height (cm)
BMI (kg/m2)
BSA (m2)
Daily energy intake, (cal/d)
3–4
543 ± 182
2.4 ± 0.4
104.4 ± 5.1
15.5 ± 1.1
0.70 ± 0.06
1403 ± 235
504 ± 213
2.2 ± 0.5
102.2 ± 5.7
15.9 ± 1.6
0.68 ± 0.07
1146 ± 234
5–6
485 ± 205
3.4 ± 0.8
117.7 ± 5.4
15.2 ± 1.1
0.83 ± 0.07
1531 ± 278
596 ± 214
2.9 ± 0.6
114.2 ± 5.0
15.5 ± 1.4
0.80 ± 0.07
1414 ± 249
7–8
710 ± 209
4.4 ± 1.2
127.5 ± 6.9
16.3 ± 1.8
0.97 ± 0.12
1825 ± 271
664 ± 264
3.7 ± 0.9
126.9 ± 5.3
15.8 ± 1.9
0.95 ± 0.10
1639 ± 308
9–10
767 ± 257
6.0 ± 1.3
142.1 ± 7.9
17.3 ± 2.0
1.18 ± 0.13
1991 ± 365
706 ± 206
5.3 ± 1.4
139.3 ± 7.6
16.9 ± 2.3
1.14 ± 0.13
1750 ± 211
11–12
922 ± 413
7.1 ± 1.8
154.1 ± 8.4
18.9 ± 3.2
1.39 ± 0.17
2081 ± 395
772 ± 310
6.4 ± 1.1
151.9 ± 7.0
18.7 ± 3.3
1.36 ± 0.18
1895 ± 430
13–14
871 ± 243
9.7 ± 3.4
163.4 ± 8.4
19.8 ± 1.8
1.56 ± 0.16
2272 ± 368
1043 ± 397
7.9 ± 1.8
161.9 ± 6.2
19.6 ± 3.4
1.53 ± 0.14
1779 ± 351
15–16
1108 ± 422
12.8 ± 2.3
174.7 ± 8.3
20.4 ± 2.2
1.75 ± 0.15
2554 ± 685
1070 ± 595
9.8 ± 2.0
167.3 ± 7.0
21.3 ± 2.8
1.67 ± 0.17
1862 ± 401
17–18
1204 ± 596
14.8 ± 4.1
180.2 ± 6.3
22.5 ± 3.0
1.92 ± 0.14
2722 ± 483
1237 ± 533
9.9 ± 2.2
170.3 ± 7.6
21.4 ± 2.8
1.72 ± 0.16
1676 ± 388
Data are mean values ± SD
25 boys and 25 girls in each age group
Data from [4, 5]
BMI body mass index, BSA body surface area
One point that has to be added is that using such more sophisticated 24-h urine volume data (as given by Beckford et al. or shown in Table 1) and measuring urinary iodine concentrations in spot samples without considering creatinine concentrations will not allow to control for variations in hydration status which can be large within and between populations [3, 6, 7]. Relating spot urine iodine and creatinine measurements to population-specific urinary 24-h creatinine reference values (or using corresponding creatinine-based prediction equations), enables to yield more accurate estimates of daily iodine excretion than relating iodine concentrations to 24-h urine volume estimates [79]. However, if no urinary creatinine measurements are available, utilizing the more specific 24-h volume estimates will definitely help to reduce misclassifications of iodine status in populations. If for research purposes highest possible accuracy for an analyte excretion rate estimation on a per-day basis is required and only spot urine collections can be performed, additional creatinine measurements should be a must.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.
download
DOWNLOAD
print
DRUCKEN

Unsere Produktempfehlungen

Neuer Inhalt

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
9.
Zurück zum Zitat Chen W, Li X, Guo X, Shen J, Tan L, Lin L, Wu Y, Wang W, Wang W, Bian J, Zhang W (2017) Urinary iodine excretion (UIE) estimated by iodine/creatinine ratio from spot urine in Chinese school-age children. Clin Endocrinol 86(4):628–633. https://doi.org/10.1111/cen.13282CrossRef Chen W, Li X, Guo X, Shen J, Tan L, Lin L, Wu Y, Wang W, Wang W, Bian J, Zhang W (2017) Urinary iodine excretion (UIE) estimated by iodine/creatinine ratio from spot urine in Chinese school-age children. Clin Endocrinol 86(4):628–633. https://​doi.​org/​10.​1111/​cen.​13282CrossRef
Metadaten
Titel
A systematic review and meta-analysis of 24-h urinary output of children and adolescents: impact on the assessment of iodine status using urinary biomarkers—don’t forget creatinine
verfasst von
Thomas Remer
Publikationsdatum
13.01.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 2/2021
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-020-02467-y

Weitere Artikel der Ausgabe 2/2021

European Journal of Nutrition 2/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.